Abstract:A multilayer concatenated catalytic aptasensing scheme is developed for in vivo aptasensing via the in situ self‐assembly of branched DNA copolymers with low mobility and numerous fluorophores. With an auxiliary tumor‐specific nanocarrier, the versatile HCRs aptasensing circuit enables the in vivo aptasensing of tumor cells with high sensitivity, high accuracy, and high adaptability. Probing endogenous molecular profiles in living entities is of fundamental significance to decipher biological functions and exploit novel theranostics. Despite programmable nucleic acid‐based aptasensing systems across the breadth of molecular imaging, an aptasensing system enabling in vivo imaging with high sensitivity, accuracy, and adaptability is highly required yet is still in its infancy. Artificial catalytic DNA circuits that can modularly integrate to generate multiple outputs from a single input in an isothermal autonomous manner, have supplemented powerful toolkits for intracellular biosensing research. Herein, a multilayer nonenzymatic catalytic DNA circuits‐based aptasensing system is devised for in situ imaging of a bioactive molecule in living mice by assembling branched DNA copolymers with high‐molecular‐weight and high‐signal‐gain based on avalanche‐mimicking hybridization chain reactions (HCRs). The HCRs aptasensing circuit performs as a general and powerful sensing platform for precise analysis of a series of bioactive molecules due to its inherent rich recognition repertoire and hierarchical reaction accelerations. With tumor‐targeting capsule encapsulation, the HCRs aptasensing circuit is specifically delivered into tumor cells and allowed the high‐contrast imaging of intracellular adenosine triphosphate in living mice, highlighting its potential for visualizing these clinically important biomolecules and for studying the associated physiological processes.

Chemical Amplification-Enabled Topological Modification of Nucleic Acid Aptamers for Enhanced Cancer-Targeted Theranostics

Aptamers: an Emerging Navigation Tool of Therapeutic Agents for Targeted Cancer Therapy

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Engineering Molecular Self-Assembly of Theranostic Nanoprobes for Dual-Modal Imaging-Guided Precise Chemotherapy

Modular Assembly of a Concatenated DNA Circuit for In Vivo Amplified Aptasensing

Bispecific Nanobody-Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors

Tunable Multivalent Aptamer-Based DNA Nanostructures to Regulate Multiheteroreceptor-Mediated Tumor Recognition.

DNA Nanotechnology-Facilitated Ligand Manipulation for Targeted Therapeutics and Diagnostics.

Novel DNA Polymer for Amplification Pretargeting

Molecular Engineering of Aptamer Self-Assemblies Increases in Vivo Stability and Targeted Recognition

Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding

Aptamer and Aptamer Pharmaceuticals

Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine

Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery

Engineered Aptamer‐Organic Amphiphile Self‐Assemblies for Biomedical Applications: Progress and Challenges

Advances In The Development Of Aptamer Drug Conjugates For Targeted Drug Delivery

A covalently conjugated branched DNA aptamer cluster-based nanoplatform for efficiently targeted drug delivery

Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy

Regulating the Anticancer Efficacy of Sgc8–Combretastatin A4 Conjugates: A Case of Recognizing the Significance of Linker Chemistry for the Design of Aptamer-Based Targeted Drug Delivery Strategies

Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging

Bio-Conjugated Advanced Materials for Targeted Disease Theranostics